Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness.
暂无分享,去创建一个
G. Van den Berghe | C. Mathieu | A. Giulietti | Greet Van den Berghe | Chantal Mathieu | Frank Weekers | W. Coopmans | E. van Herck | Anna-Paula Giulietti | Marina Michalaki | Willy Coopmans | Erik Van Herck | F. Weekers | M. Michalaki
[1] R. Mindham,et al. PARKINSONISM INDUCED BY FLUPHENAZINE DECANOATE , 1976, The Lancet.
[2] R. Cooper,et al. Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans. , 2002, American journal of physiology. Endocrinology and metabolism.
[3] G. Van den Berghe,et al. A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response. , 2002, Endocrinology.
[4] A. Imrich,et al. Immunologic effects of acute hyperglycemia in nondiabetic rats. , 1997, JPEN. Journal of parenteral and enteral nutrition.
[5] N R Webster,et al. Increased mortality associated with growth hormone treatment in critically ill adults. , 1999, The New England journal of medicine.
[6] D. Chinkes,et al. Anabolic Effects of Oxandrolone After Severe Burn , 2001, Annals of surgery.
[7] D. Sodi-Pallares,et al. Potassium, glucose, and insulin in myocardial infarction. , 1969, Lancet.
[8] Y. Kaneda,et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.
[9] G. Berghe. Dynamic neuroendocrine responses to critical illness , 2002, Frontiers in Neuroendocrinology.
[10] C. Mathieu,et al. In Vitro and In Vivo Analysis of the Immune System of Vitamin D Receptor Knockout Mice , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[11] K. Federlin,et al. Impairment of Polymorphonuclear Leukocyte Function and Metabolic Control of Diabetes , 1992, Diabetes Care.
[12] K. Feingold,et al. Infection and inflammation-induced proatherogenic changes of lipoproteins. , 2000, The Journal of infectious diseases.
[13] L. Broemeling,et al. Effects of recombinant human growth hormone on donor-site healing in severely burned children. , 1990, Annals of surgery.
[14] Nielson Cp,et al. Inhibition of Polymorphonuclear Leukocyte Respiratory Burst by Elevated Glucose Concentrations in Vitro , 1989 .
[15] F. Zannad,et al. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus. , 2001, Diabetes & metabolism.
[16] A. Aljada,et al. Insulin Inhibits Intranuclear Nuclear Factor κB and Stimulates IκB in Mononuclear Cells in Obese Subjects: Evidence for an Anti-inflammatory Effect? , 2001 .
[17] R. Kernohan,et al. Potassium, glucose, and insulin in myocardial infarction. , 1967, Lancet.
[18] C. Pison,et al. Glucose modulates hemodynamic, metabolic, and inflammatory responses to lipopolysaccharide in rabbits. , 1997, Journal of applied physiology.
[19] M. Saad,et al. Insulin regulates plasma ghrelin concentration. , 2002, The Journal of clinical endocrinology and metabolism.
[20] G. Van den Berghe,et al. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. , 2003, The Journal of clinical endocrinology and metabolism.
[21] D. Chinkes,et al. Efficacy of a high-carbohydrate diet in catabolic illness , 2001, Critical care medicine.
[22] M. Kasuga,et al. Low phagocytic activity of resident peritoneal macrophages in diabetic mice: relevance to the formation of advanced glycation end products. , 1999, Diabetes.
[23] G. Van den Berghe,et al. Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. , 1999, The Journal of clinical endocrinology and metabolism.
[24] D. Dunger,et al. Recombinant human insulin-like growth factor-I abolishes changes in insulin requirements consequent upon growth hormone pulsatility in young adults with type I diabetes mellitus. , 1998, Metabolism: clinical and experimental.
[25] R. Wolfe,et al. The effect of prolonged euglycemic hyperinsulinemia on lean body mass after severe burn. , 2002, Surgery.
[26] T. Tani,et al. Treatment of septic shock with a protease inhibitor in a canine model: A prospective, randomized, controlled trial , 1993, Critical care medicine.
[27] N. McLetchie. Alloxan diabetes: The sorcerer and his apprentice , 1982, Diabetologia.
[28] K. Asadullah,et al. Monocyte deactivation in septic patients: Restoration by IFN-γ treatment , 1997, Nature Medicine.
[29] E. Schleicher,et al. Elevated glucose levels stimulate transforming growth factor-beta 1 (TGF-beta 1), suppress interleukin IL-2, IL-6 and IL-10 production and DNA synthesis in peripheral blood mononuclear cells. , 1996, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[30] M Schetz,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[31] P. Barie,et al. Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. , 1996, Critical care medicine.
[32] G. Grunkemeier,et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. , 1997, The Annals of thoracic surgery.
[33] C. Stehouwer,et al. The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II Diabetic subjects , 2000, Diabetologia.
[34] Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. , 1999 .
[35] B. Wajchenberg,et al. Effect of glycemic control on growth hormone and IGFBP-1 secretion in patients with type I diabetes mellitus , 1996, Journal of endocrinological investigation.
[36] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[37] H. Baumann,et al. Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes. , 1992, Molecular and cellular biology.
[38] G. Gaulton,et al. Assessment of the diabetogenic drugs alloxan and streptozotocin as models for the study of immune defects in diabetic mice , 1985, Diabetologia.
[39] D. Chinkes,et al. Stimulation of Muscle Protein Synthesis by Long‐Term Insulin Infusion in Severely Burned Patients , 1995, Annals of surgery.
[40] L. Gavin,et al. Glucose and insulin reverse the effects of fasting on 3,5,3'-triiodothyronine neogenesis in primary cultures of rat hepatocytes. , 1987, Endocrinology.
[41] B A Mizock,et al. Alterations in carbohydrate metabolism during stress: a review of the literature. , 1995, The American journal of medicine.
[42] W. Fraser,et al. Neutrophil Bactericidal Function in Diabetes Mellitus: Evidence for Association with Blood Glucose Control , 1995, Diabetic medicine : a journal of the British Diabetic Association.
[43] G. Dhonneur,et al. Impairment of polymorphonuclear neutrophil functions precedes nosocomial infections in critically ill patients , 2002, Critical care medicine.
[44] D. Chinkes,et al. A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. , 1999, Annals of surgery.
[45] H. Sheehan,et al. NECROSIS OF ISLETS OF LANGERHANS PRODUCED EXPERIMENTALLY , 1943 .
[46] U. Das. Is insulin an antiinflammatory molecule? , 2001, Nutrition.
[47] A. Beddoe,et al. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. , 1987, The Journal of trauma.